Combination of active targeting, enzyme-triggered release and fluorescent dye into gold nanoclusters for endomicroscopy-guided photothermal/photodynamic therapy to pancreatic ductal adenocarcinoma

• Published in: Biomaterials 2017-09, Vol.139, p.30-38
• Main Authors: Li, Hui, Wang, Ping, Deng, Yunxiang, Zeng, Meiying, Tang, Yan, Zhu, Wei-Hong, Cheng, Yingsheng
• Format: Article
• Language: English
• Subjects: Advanced Basic Science; Animals; Antineoplastic Agents - chemical synthesis; Antineoplastic Agents - therapeutic use; Carbocyanines - chemistry; Carcinoma, Pancreatic Ductal - drug therapy; Cathepsin E - metabolism; Cell Line, Tumor; Dentistry; Enzyme-triggered release; Fluorescent bioimaging; Gold - administration & dosage; Gold nanoclusters; Humans; Metal Nanoparticles - administration & dosage; Mice; Mice, Nude; Microscopy, Confocal; Optical Imaging; Pancreatic ductal adenocarcinoma; Pancreatic Neoplasms - drug therapy; Peptides - chemical synthesis; Peptides - chemistry; Peptides - therapeutic use; Photochemotherapy - methods; Photothermal and photodynamic therapy; Prodrugs - chemistry; Treatment Outcome; Xenograft Model Antitumor Assays
• ISSN: 0142-9612; 1878-5905
• DOI: 10.1016/j.biomaterials.2017.05.030

Abstract Pancreatic ductal adenocarcinoma (PDAC) is one of the most devastating malignancies in patients, and there is an urgent need for an effective treatment method. Herein, we report a novel gold nanocluster-based platform for confocal laser endomicroscopy-guided photothermal therapy (PTT) / photodynamic therapy (PDT) for PDAC, which consists of four components: the PTT-carrier gold nanocluster, an active targeting ligand U11 peptide, a Cathepsin E (CTSE)-sensitive PDT therapy prodrug, and a CTSE-sensitive imaging agent (cyanine dye Cy5.5). Due to the strong coupling among cross-linked gold nanoparticles (AuNPs), the surface plasmon resonance peak of nanoclusters shifts to the near-infrared (NIR) region, thus making the nanoclusters useful in the effective PTT therapy. In the system, the labeling of nanoclusters with U11 peptide can distinctly increase their affinity and accelerate their uptake by pancreatic cancer cells. Cell apoptosis staining demonstrates that, upon incoporation of the uPAR-targeted unit, the antitumor efficacy of CTSE-sensitive nanocluster AuS-U11 is significantly enhanced with respect to that of the non-targeted nanocluster AuS-PEG and the insensitive nanocluster AuC-PEG. In vivo and ex vivo optical imaging confirms the high accumulation of AuS-U11 in the in situ pancreatic tumor model. Therapeutic studies further show that the combination of active targeting for tumor tissue, enzyme-triggered drug release of 5-ALA and fluorescent dye Cy5.5 in nanoclusters AuS-U11 could achieve optimal therapeutic efficacy with endomicroscopy-guided photothermal/photodynamic therapy with minimal side effects. As a consequence, the delicate gold nanocluster concept provides a promising strategy to enhance the therapy efficiency in the most challenging PDAC treatment.